Banner

Human ACE-2, MCP1 and micro-RNA 146 as Novel Markers for COVID- 19 Affection and Severity

• 2022
Back
Publication Information
Authors AL-Shaimaa M. AL-Tabbakh10
Keywords Not Available
Journal Not Available
Publisher Not Available
Volume Not Available
Issue Not Available
Pages Not Available
publication.type International
Paper Link Not Available
Supplementary Materials Not Available
Abstract
Background & Aims: Coronavirus disease - 2019 (COVID-19) is a major pandemic that
causes high morbidity and mortality rates. Aim of this study: to detect the relations between many risk
factors, ACE-2, MCP-1, Micro RNA 146 gene expression, and COVID-19 infection and disease severity.
Methods: This study was carried out on 165 cases of COVID-19 and 138 controls. ACE2 and MCP1
levels were measured in COVID-19 cases and control by ELISA and micro-RNA-146 expression by
PCR.
Results: We found an increased blood level of ACE2 and MCP1 in COVID- 19 patients than in
healthy persons and a significant down-regulation of micro-RNA 146 gene expression in cases than in
controls. There was a significant correlation between increased blood level of ACE2, regulation of
micro-RNA 146 gene expression and severity of lung affection, a significant correlation was found
between increased blood level of MCP1 and thrombosis in COVID-19 patients. Neurological complications
were significantly correlated with more viral load, more ACE2 blood level, and down regulation
of micro RNA146 expression.
Conclusion: High viral load, increased blood level of ACE2, and down-regulation of micro-RNA 146
expression are associated with more severe lung injury and the presence of neurologic complications
like convulsions and coma in COVID-19 Egyptian patients.